Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06440993
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-05-29
Brief Title:
Durvalumab Intraductal Radiofrequency Ablation ID-RFA in Extrahepatic Cholangiocarcinoma
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization Data
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Class:
OTHER
Study ID:
CLEAN-DUCT TRITICC-3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Universitätsklinikum Düsseldorf Germany | UNKNOWN |
| Universitätsklinikum Köln Germany | UNKNOWN |
| AstraZeneca | INDUSTRY |